Stock Information
Gilead Sciences Inc (GILD)
Ticker Symbol: GILD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $150,410,614,357.00 mil
Piotroski score: 7
PE Ratio: 19.0768
EPS (TTM): 6.4341
Revenue (TTM): $23.20 M
Dividend Yield: 2.534082%
ROE: 40.74%
Latest News
-
Dividend Champion, Contender, And Challenger Highlights: Week Of December 28
Fri, Dec 26, 2025 11:16 PM
-
Can Amgen Sustain Its Rally In 2026
Fri, Dec 26, 2025 1:03 PM
-
Gilead Sciences to acquire Repare’s RP-3467
Fri, Dec 26, 2025 9:16 AM
-
Sector Update: Health Care Stocks Rise Wednesday Afternoon
Wed, Dec 24, 2025 5:08 PM
-
Update: Gilead Sciences to Acquire Repare Therapeutics' Investigational Cancer Treatment; Repare Shares Rise
Wed, Dec 24, 2025 2:49 PM
-
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
Wed, Dec 24, 2025 12:00 PM
-
GILD Exercises Option to License Assembly Bio's Herpes Programs
Tue, Dec 23, 2025 3:45 PM
-
Gilead Sciences to Present at Upcoming Investor Conference
Mon, Dec 22, 2025 9:05 PM
-
Gilead Sciences Exercises Option With Assembly Bio to License Herpes Drugs
Mon, Dec 22, 2025 2:33 PM
-
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
Mon, Dec 22, 2025 1:00 PM
Key Financials
Financial data not available
